Higher levels of CRP in C3-AITL patients might be explained by the higher frequency of either IDH2 or multiple TET2 mutations, as Tet2 recruits Hdac2 and represses IL-6 transcription via histone deacetylation [51]. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.